Hypofractionated LocoRegional Radiotherapy in Breast Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The primary objective of this study is to determine if hypofractionated RT delivered over 1 week to the breast or chest wall and regional nodes (26Gy in 5 daily fractions) following BCS or mastectomy, is non-inferior to conventional fractionation to the breast or chest wall and regional nodes delivered over 3 weeks (40Gy in 15 daily fractions) in patients with node-positive breast cancer.
Epistemonikos ID: 21244ae7423694d41dd82c82f78fdacb0e64ac89
First added on: May 07, 2024